AHA 2022 Conference Coverage
M

AHA 2022: Genomic Therapies for Hereditary Transthyretin (TTR) Amyloidosis

By AHA 2022 Conference Coverage FEATURING Marianna Fontana
By AHA 2022 Conference Coverage FEATURING Marianna Fontana
279 views
November 29, 2022
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
37:56
CCM® Therapy

CCM® Therapy — My Approach to Identifying Patients

Feat. M. Emig, S. Toth-Manikowski, D. McCaskill
19:54

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

28 views
12:18
CCM® Therapy

HRS 2024: Cardiac Contractility Modulation - Don’t Wait!

Feat. R. Kahwash
35:16

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

5.4K views
40:17

Heart Failure with Preserved Ejection Fraction: Current Perspectives…

American College of Cardiology

S. Shah

2.3K views
10:09

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

136 views
16:45

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

136 views
12:30

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

187 views
17:29

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

239 views
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
06:23
CVRx | Barostim

ESC 2023: Baroreflex Activation Therapy for HFrEF Patients: Long-Ter…

Feat. W. Abraham, F. Arribas, M. Zile
12:21
CVRx | Barostim

Baroreflex Activation Therapy Overview of Clinical Data

Feat. L. Tsao
28:03

How to Detect and Treat Heart Failure with Preserved Ejection Fracti…

Houston Methodist DeBakey Heart and Vascular Center

317 views
16:11

Extended Anticoagulation for VTE

Jeffrey Weitz

3.1K views
11:50

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

1.5K views
19:30

ISCHEMIA Trial: Are We Overusing Cardiac Stents? Is Revascularizatio…

American Heart & Vascular Institute

B. Reddy

3.5K views
21:36

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

798 views
47:48

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

53 views